CureVac

CureVac

Fighting for human health

Human health & social work | Germany | Capacity Building |

 

Overview

CureVac is the first company to successfully harness messenger RNA (mRNA) for medical purposes. The principle is promising use natural mRNA as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases.

Industry

Legal Structure

Operating Status

Employees

Human health & social work Operating 201 - 500 employees

Funding and Financing Rounds


Team

  • Ingmar Hoerr

    Chairman of the Executive Board / Chief Executive


Impact

Geographies:

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

Paul Ehrlich Str. 15 72076
Tübingen, Germany



Explore

Revision History

Last Update: Oct 07, 2017 5:00 p.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2024 IMPACTSPACE. ALL RIGHTS RESERVED.